These changes were found in people who had very mild or no cognitive symptoms, suggesting that the retina could act as an ...

Deep sleep could be key to forestalling slow declines in brain health that may one day lead to Alzheimer's disease, the most ...

AZ entered the AL amyloidosis arena via its $39 billion takeover ... Neurotech's cell therapy gets FDA nod for eye disorder MacTe... Neurotech Pharma's cell therapy Encelto has become the first ...

More than three decades after the EPA added Fort Ord to its list of most contaminated places, the former base is still being ...

Eisai and Biogen have been unable to persuade the medicines regulator in Australia to approve their Alzheimer's disease ...

A so-called 'miracle' Alzheimer's drug caused brain bleeds in more than a third of patients, a new study has revealed.

Learn how astronauts can lose bone density and how muscles can weaken. As we continue to explore space, NASA is looking into ...

Research shows poor sleep quality accelerates brain aging by up to 2.6 years in middle-aged adults, doubling cognitive ...

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that ...

Your brain’s natural rinse cycle flows while you sleep. A new study suggests certain medications interfere with that important nightly ritual.

Learn more about whether Alnylam Pharmaceuticals, Inc. or argenx SE is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Related Eye test may diagnose Alzheimer's Except for cancer ... and phosphorylated tau 181 is linked to the buildup of toxic amyloid proteins in the brain, a hallmark of Alzheimer's disease. "Having ...